Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies
Overview
Authors
Affiliations
Child-Pugh and MELD scores have been widely used for the assessment of prognosis in liver cirrhosis. A systematic review and meta-analysis aimed to compare the discriminative ability of Child-Pugh versus MELD score to assess the prognosis of cirrhotic patients.PubMed and EMBASE databases were searched. The statistical results were summarized from every individual study. The summary areas under receiver operating characteristic curves, sensitivities, specificities, positive and negative likelihood ratios, and diagnostic odds ratios were also calculated.Of the 1095 papers initially identified, 119 were eligible for the systematic review. Study population was heterogeneous among studies. They included 269 comparisons, of which 44 favored MELD score, 16 favored Child-Pugh score, 99 did not find any significant difference between them, and 110 did not report the statistical significance. Forty-two papers were further included in the meta-analysis. In patients with acute-on-chronic liver failure, Child-Pugh score had a higher sensitivity and a lower specificity than MELD score. In patients admitted to ICU, MELD score had a smaller negative likelihood ratio and a higher sensitivity than Child-Pugh score. In patients undergoing surgery, Child-Pugh score had a higher specificity than MELD score. In other subgroup analyses, Child-Pugh and MELD scores had statistically similar discriminative abilities or could not be compared due to the presence of significant diagnostic threshold effects.Although Child-Pugh and MELD scores had similar prognostic values in most of cases, their benefits might be heterogeneous in some specific conditions. The indications for Child-Pugh and MELD scores should be further identified.
Jing Y, Jing J, Sun X, Jin Y, Bai X Front Oncol. 2025; 15:1537688.
PMID: 40046626 PMC: 11879819. DOI: 10.3389/fonc.2025.1537688.
The Role of Machine Learning Models in Predicting Cirrhosis Mortality: A Systematic Review.
Mohamud K, Elzubair Eltahir S, Ahmed Alhardalo H, Albashir H, Ali Mohamed Zain N, Abdelrahman Ibrahim M Cureus. 2025; 17(1):e78155.
PMID: 40026938 PMC: 11867977. DOI: 10.7759/cureus.78155.
Update on the Complications and Management of Liver Cirrhosis.
Fadlallah H, El Masri D, Bahmad H, Abou-Kheir W, El Masri J Med Sci (Basel). 2025; 13(1).
PMID: 39982238 PMC: 11843904. DOI: 10.3390/medsci13010013.
Liu Q, He Y, Yang F, Guo G, Yang W, Wu L Sci Prog. 2025; 108(1):368504251320157.
PMID: 39967253 PMC: 11837080. DOI: 10.1177/00368504251320157.
Disease trajectory and competing risks of patients with cirrhosis in the US.
Mohammadi M, Hasjim B, Balbale S, Polineni P, Huang A, Paukner M PLoS One. 2025; 20(2):e0313152.
PMID: 39951428 PMC: 11828360. DOI: 10.1371/journal.pone.0313152.